Restorative Neurotechnologies secures new round of €3 million

Restorative has successfully secured €3 million in a Series A funding round. The funding was co-led by Cdp Venture Capital Sgr, through the Italia Venture II Fund, which supports the growth of startups and innovative SMEs in Southern Italy, and by Fondazione ENEA Tech e Biomedical, an agency dedicated to enhancing research, development, and technology transfer in Italy’s biomedical sector.

Restorative Neurotechnologies secures new round of €3 million

The round also saw participation from long-standing investors such as MMP (Manilo Marocco Partners) and IAG (Italian Angels for Growth). Additionally, discussions are underway with other potential investors, with plans to raise an additional €1 million by the end of the year.

How the funds will be used

The funds will be used to accelerate the adoption of MindLenses Professional across Europe, which is already eligible for inclusion in national public healthcare reimbursement systems within the EU. Restorative also plans to expand MindLenses’ application to conditions like Alzheimer’s, prepare for entry into the U.S. market through the FDA approval process, and launch a new product utilizing its non-invasive neuromodulation technology aimed at improving cognitive health for a broader audience.